US Stock MarketDetailed Quotes

Relmada Therapeutics (RLMD)

Watchlist
  • 7.050
  • -0.160-2.22%
Trading Apr 27 15:50 ET
739.46MMarket Cap-4.86P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Relmada Therapeutics (RLMD) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-29.55%59.1M
6.59%20.33M
-55.12%10.33M
-45.69%10.22M
-20.75%18.22M
-19.10%83.89M
-28.90%19.08M
1.39%23.01M
-27.69%18.82M
-18.35%22.99M
Selling and administrative expenses
-14.57%32.22M
51.82%12.26M
-46.95%6.29M
-8.59%7.4M
-35.27%6.27M
-22.86%37.72M
-33.13%8.08M
-3.10%11.86M
-34.09%8.1M
-21.23%9.68M
-General and administrative expense
-14.57%32.22M
51.82%12.26M
-46.95%6.29M
-8.59%7.4M
-35.27%6.27M
-22.86%37.72M
-33.13%8.08M
-3.10%11.86M
-34.09%8.1M
-21.23%9.68M
Research and development costs
-41.79%26.88M
-26.61%8.07M
-63.80%4.04M
-73.70%2.82M
-10.18%11.95M
-15.75%46.18M
-25.43%11M
6.65%11.15M
-21.97%10.72M
-16.11%13.31M
Operating profit
29.55%-59.1M
-6.59%-20.33M
55.12%-10.33M
45.69%-10.22M
20.75%-18.22M
19.10%-83.89M
28.90%-19.08M
-1.39%-23.01M
27.69%-18.82M
18.35%-22.99M
Net non-operating interest income expense
-60.45%1.4M
-40.85%387.23K
-71.16%247.01K
-66.62%321.46K
-58.30%440.29K
-31.48%3.53M
-48.01%654.64K
-35.19%856.48K
-29.37%963.01K
-12.57%1.06M
Non-operating interest income
-60.45%1.4M
-40.85%387.23K
-71.16%247.01K
-66.62%321.46K
-58.30%440.29K
-31.48%3.53M
-48.01%654.64K
-35.19%856.48K
-29.37%963.01K
-12.57%1.06M
Other net income (expense)
-16.41%319.05K
133.07%78.12K
-102.62%-11.16K
-61.89%33.41K
110.58%218.68K
258.26%381.66K
-158.34%-236.22K
167.59%426.39K
113.70%87.65K
-83.37%103.85K
Gain on sale of security
-16.41%319.05K
133.07%78.12K
-102.62%-11.16K
-61.89%33.41K
110.58%218.68K
258.26%381.66K
-158.34%-236.22K
167.59%426.39K
113.70%87.65K
-83.37%103.85K
Income before tax
28.25%-57.39M
-6.49%-19.87M
53.55%-10.09M
44.47%-9.87M
19.56%-17.56M
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
Income tax
Net income
28.25%-57.39M
-6.49%-19.87M
53.55%-10.09M
44.47%-9.87M
19.56%-17.56M
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
Net income continuous Operations
28.25%-57.39M
-6.49%-19.87M
53.55%-10.09M
44.47%-9.87M
19.56%-17.56M
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
Minority interest income
Net income attributable to the parent company
28.25%-57.39M
-6.49%-19.87M
53.55%-10.09M
44.47%-9.87M
19.56%-17.56M
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
28.25%-57.39M
-6.49%-19.87M
53.55%-10.09M
44.47%-9.87M
19.56%-17.56M
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
Basic earnings per share
45.28%-1.45
56.30%-0.2709
58.33%-0.3
49.15%-0.3
19.44%-0.58
19.21%-2.65
25.30%-0.62
1.37%-0.72
29.76%-0.59
17.24%-0.72
Diluted earnings per share
45.28%-1.45
56.30%-0.2709
58.33%-0.3
49.15%-0.3
19.44%-0.58
19.21%-2.65
25.30%-0.62
1.37%-0.72
29.76%-0.59
17.24%-0.72
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -29.55%59.1M6.59%20.33M-55.12%10.33M-45.69%10.22M-20.75%18.22M-19.10%83.89M-28.90%19.08M1.39%23.01M-27.69%18.82M-18.35%22.99M
Selling and administrative expenses -14.57%32.22M51.82%12.26M-46.95%6.29M-8.59%7.4M-35.27%6.27M-22.86%37.72M-33.13%8.08M-3.10%11.86M-34.09%8.1M-21.23%9.68M
-General and administrative expense -14.57%32.22M51.82%12.26M-46.95%6.29M-8.59%7.4M-35.27%6.27M-22.86%37.72M-33.13%8.08M-3.10%11.86M-34.09%8.1M-21.23%9.68M
Research and development costs -41.79%26.88M-26.61%8.07M-63.80%4.04M-73.70%2.82M-10.18%11.95M-15.75%46.18M-25.43%11M6.65%11.15M-21.97%10.72M-16.11%13.31M
Operating profit 29.55%-59.1M-6.59%-20.33M55.12%-10.33M45.69%-10.22M20.75%-18.22M19.10%-83.89M28.90%-19.08M-1.39%-23.01M27.69%-18.82M18.35%-22.99M
Net non-operating interest income expense -60.45%1.4M-40.85%387.23K-71.16%247.01K-66.62%321.46K-58.30%440.29K-31.48%3.53M-48.01%654.64K-35.19%856.48K-29.37%963.01K-12.57%1.06M
Non-operating interest income -60.45%1.4M-40.85%387.23K-71.16%247.01K-66.62%321.46K-58.30%440.29K-31.48%3.53M-48.01%654.64K-35.19%856.48K-29.37%963.01K-12.57%1.06M
Other net income (expense) -16.41%319.05K133.07%78.12K-102.62%-11.16K-61.89%33.41K110.58%218.68K258.26%381.66K-158.34%-236.22K167.59%426.39K113.70%87.65K-83.37%103.85K
Gain on sale of security -16.41%319.05K133.07%78.12K-102.62%-11.16K-61.89%33.41K110.58%218.68K258.26%381.66K-158.34%-236.22K167.59%426.39K113.70%87.65K-83.37%103.85K
Income before tax 28.25%-57.39M-6.49%-19.87M53.55%-10.09M44.47%-9.87M19.56%-17.56M19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M
Income tax
Net income 28.25%-57.39M-6.49%-19.87M53.55%-10.09M44.47%-9.87M19.56%-17.56M19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M
Net income continuous Operations 28.25%-57.39M-6.49%-19.87M53.55%-10.09M44.47%-9.87M19.56%-17.56M19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M
Minority interest income
Net income attributable to the parent company 28.25%-57.39M-6.49%-19.87M53.55%-10.09M44.47%-9.87M19.56%-17.56M19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 28.25%-57.39M-6.49%-19.87M53.55%-10.09M44.47%-9.87M19.56%-17.56M19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M
Basic earnings per share 45.28%-1.4556.30%-0.270958.33%-0.349.15%-0.319.44%-0.5819.21%-2.6525.30%-0.621.37%-0.7229.76%-0.5917.24%-0.72
Diluted earnings per share 45.28%-1.4556.30%-0.270958.33%-0.349.15%-0.319.44%-0.5819.21%-2.6525.30%-0.621.37%-0.7229.76%-0.5917.24%-0.72
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.22%
Sample Name
Sample Code
 +8.60%
Sample Name
Sample Code
 +7.74%
4
VanEck Oil Services ETF
OIH
+5.87%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.90%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.41%
Sample Name
Sample Code
 +6.85%
Sample Name
Sample Code
 +4.90%
4
Chagee Holdings
CHA
+3.37%
5
Qifu Technology
QFIN
+0.56%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -